Description
All participants on this study will be given a set of tests called neuropsychological tests. The tests will be used to learn about the participant's neuropsychological and behavioral functioning (for example: thinking, learning and remembering). While the participant is taking the assessments, the participant's parent (or another person who knows the participant well) will fill in answers to a set of written questions. The tests used in this study are not being used to evaluate a child's intelligence. Rather, the assessments are used for research to determine effects of the treatment. All participants will have 3 testing sessions, each lasting about 1 hour. The first assessment will take place around 9 months after the participant was diagnosed with cancer. The second assessment will take place around 30 months after the participant was diagnosed with cancer. The last assessment will take place around 60 months (5 years) after the participant was diagnosed with cancer.
Eligibility
Must be currently enrolled in a COG therapeutic study that aims to examine neuropsychological, social, emotional, and/or behavioral functioning
Must have receptive and expressive language skills in English since the assessment instruments are standardized and validated among English-speakers
Must not have a history of severe or profound mental retardation (that is to say, IQ less than or equal to 50). Please note that patients with a prior history of attention deficit hyperactivity disorder (ADHD) or a specific learning disability (for example, dyslexia) are eligible